Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in African-American patients with hypertension.

Journal of clinical hypertension (Greenwich, Conn.)

Volumn 6, Issue 6, 2004, Pages 310-314

  Papademetriou, Vasilios ^a   Narayan, Puneet ^a   Kokkinos, Peter ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; TETRAZOLE DERIVATIVE;

AFRICAN AMERICAN; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG COMBINATION; DRUG EFFECT; ETHNOLOGY; HUMAN; HYPERTENSION; MIDDLE AGED; PUBLIC HOSPITAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AFRICAN AMERICANS; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZIMIDAZOLES; BLOOD PRESSURE; CROSS-OVER STUDIES; DRUG THERAPY, COMBINATION; ENALAPRIL; HOSPITALS, VETERANS; HUMANS; HYPERTENSION; MIDDLE AGED; TETRAZOLES; TREATMENT OUTCOME;

EID: 4944225538     PISSN: 15246175     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2004.03446.x     Document Type: Article

References (0)